Instil Bio, Inc. Public Float
Instil Bio, Inc. (TIL) had Public Float of $83.40 million as of 2025-06-30, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-27
- 2025-06-30: Entity Public Float $83.40M.
- 2024-06-28: Entity Public Float $38.60M.
- 2023-06-30: Entity Public Float $34.40M.
- 2022-06-30: Entity Public Float $285.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $83.40M 10-K · filed 2026-03-27 |
| 2024-06-28 | $38.60M 10-K · filed 2025-03-04 |
| 2023-06-30 | $34.40M 10-K · filed 2024-03-21 |
| 2022-06-30 | $285.70M 10-K · filed 2023-03-31 |
| 2021-06-30 | $1.07B 10-K · filed 2022-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |